Versar, Inc. VSR
VSR continued to play the role of this week’s most interesting pick on Thursday. The action in this play has been significant, and it has led to several potentially profitable swings since we first picked it up on Tuesday at a low of 3.70.
Yesterday we re-iterated our interest, stating that the kind of volatility we had seen in VSR to that point could certainly lead to further bounce opportunities, and we were correct in that assumption. In early trading, we witnessed a swing from 6.56 to the daily high of 7.817, a 19% move. We then watched as VSR spent a good portion of the afternoon in pullback mode before bouncing off of support at in the 5.20’s.
The stock is up in premarket trading again today with highs of over $6 so far, so for the fourth straight day we’ll have our eye on possible bounce action from VSR
Eagle Bulk Shipping EGLE
We tagged EGLE yesterday morning on the heels of a financial restructuring that led to a serious boost in PPS. The stock was up so much in fact, it was briefly halted early in the session. When trading resumed at 11AM, the stock still went on to make one heck of a move.
From an initial low of 12.02, the EGLE barreled its way up to a high of 17.00, a solid 41% increase on the day on significantly high volume.
iBio, Inc. IBIO
IBIO is a play that we’ve been tracking for some time, and it too posted a notable swing yesterday afternoon, as it rose up from 1.63 to touch 1.93, an 18% increase. The stock is also gapping up in the premarket this morning, having re-breached the $2-mark.
Repros Therapeutics, Inc. RPRX
This is a stock we caught this morning, noticing that it is gapping down 52-week lows in the pre-market. The company had some negatively received FDA news this morning. This kicks in our ‘vulture’ mindset, where we monitor a struggling play for signs of a turnaround and subsequent bounce. We can’t even begin to recall how many times we’ve turned a beaten-down stock into a winning trade on the rebound but rest assured, its enough for us to keep a close watch over RPRX moving forward.
Extended Watchlist:
APT, CYTR, ESI, AKS